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Abstract
Propensity score (PS) methods have been used extensively to adjust for confounding factors in the 
statistical analysis of observational data in comparative effectiveness research. There are four 
major PS-based adjustment approaches: PS matching, PS stratification, covariate adjustment by 
PS, and PS-based inverse probability weighting (IPW). Though covariate adjustment by PS is one 
of the most frequently used PS-based methods in clinical research, the conventional variance 
estimation of the treatment effects estimate under covariate adjustment by PS is biased. As Stampf 
et al. have shown, this bias in variance estimation is likely to lead to invalid statistical inference 
and could result in erroneous public health conclusions (e.g. food and drug safety, adverse events 
surveillance). To address this issue, we propose a two-stage analytic procedure to develop a valid 
variance estimator for the covariate adjustment by PS analysis strategy. We also carry out a simple 
empirical bootstrap resampling scheme. Both proposed procedures are implemented in an R 
function for public use. Extensive simulation results demonstrate the bias in the conventional 
variance estimator, and show that both proposed variance estimators offer valid estimates for the 
true variance and they are robust to complex confounding structures. The proposed methods are 
illustrated for a post-surgery pain study.
Keywords
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 1. Introduction
Though the randomized controlled trial (RCT) is considered to be the gold standard to 
establish drug efficacy, RCTs have their limitations and cannot always be conducted in 
*Correspondence to: Baiming Zou, Department of Biostatistics, University of Florida, Gainesville, FL 32611, USA. 
HHS Public Access
Author manuscript
Stat Med. Author manuscript; available in PMC 2017 September 10.
Published in final edited form as:













practice (e.g. [1]). Data from observational studies or electronic medical records, on the 
other hand, are readily available and often used as alternatives for evaluating comparative 
therapy effectiveness, food and drug safety, adverse events surveillance, etc. The key 
difference between data from observational studies and RCTs is that the treatment 
assignment in observational studies is not random. Instead, under the observational design, 
treatment allocations are primarily made by physicians according to various factors, such as 
patient’s disease severity, physical condition, physician’s preference and so on. The non-
randomness in treatment assignment could lead to imbalanced baseline characteristics which 
might be confounded with treatment effects. Without appropriate adjustment, erroneous 
conclusions can occur.
Various confounding adjustment methods have been proposed, among them, the commonly 
used approach is the propensity score (PS) method of Rosenbaum and Rubin [2]. The 
propensity score of a given subject is defined as the conditional probability of assigning the 
subject to a particular treatment given his or her observed covariates. The basic idea of 
propensity score is to mimic RCTs under observational designs to balance the baseline 
covariates via a simple summary statistic, i.e. the propensity score. Rosenbaum and Rubin 
[2] have shown that under certain conditions, subjects with identical propensity scores will 
have the same baseline covariate distributions regardless of which treatment group they 
come from. They demonstrated that if the treatment assignment is strongly ignorable (i.e. 
condition (1.3) of Rosenbaum and Rubin [2]) where all the confounding variables are 
observed and included in the propensity score model, conditional on propensity scores, an 
unbiased treatment effect estimate can be obtained.
In practice, the propensity score is unobserved and needs to be estimated, for example, by a 
logistic regression model. Once estimated, the propensity score can be used to adjust for 
confounding factors based on different strategies: PS matching, PS stratification, covariate 
adjustment by PS, and PS-based inverse probability weighting. Among different PS-based 
methods, the PS covariate adjustment analysis, where the estimated PS is used as a covariate 
in the second stage regression analysis, is the most straightforward PS method and often 
used in clinical research [3]. One typical application of such covariate adjustment addresses 
the safety concerns of aprotinin [4]. Although unbiased treatment effect estimates can be 
obtained via different PS methods, under some conditions, as shown by Rosenbaum and 
Rubin [2], the treatment effects estimate through PS covariate adjustment could be biased if 
the linearity assumption between the outcome and the propensity score does not hold [3]. 
Furthermore, the variance estimation of treatment effects estimate under the conventional PS 
covariate adjustment analysis is biased. As Stampf et al. [5] recently demonstrated in their 
paper: the variance estimation of the treatment effect estimate from the traditional PS 
covariate adjustment analysis scheme is biased. Our simulation results (Table 1) further 
demonstrate this problem. The biased variance estimation issue of other PS-based methods 
is also reflected in the simulation studies of Stampf et al. [5] in which they propose an 
analytic formula for PS stratification based analysis but not for the PS covariate adjustment 
approach. The biased variance estimation issue under PS framework results from the fact 
that the propensity score is an estimated quantity instead of an observed variable. An [6] and 
Zigler et al. [7] proposed a joint modeling strategy under a Bayesian framework to address 
this issue. In this paper, we provide two variance estimators of the treatment effect estimate 
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for covariate adjustment by PS under a frequentist framework. We first adopt a two-stage 
analysis strategy (e.g. [8]) to develop an analytic variance estimator. This is particularly 
useful for big observational data in comparative effectiveness research where there often 
exists hundreds of covariates with millions of observations. We also implement an empirical 
bootstrap procedure (e.g. [9]). The bootstrap estimator is conceptually simple to compute but 
it involves a heavy computational workload.
The rest of the paper is organized as follows. In Section 2, we provide a detailed description 
of the proposed variance estimators. Complete mathematical derivations of the asymptotic 
results for the analytic variance estimator and the R function implementing both the analytic 
and empirical procedures are given in the Appendix. Extensive simulation results are 
presented in Section 3 under various confounding structures to evaluate the finite sample 
performance of the proposed variance estimators. We apply the proposed methods to a post-
surgery pain study in Section 4. Concluding remarks are given in Section 5.
 2. Proposed Variance Estimation Methods
To fix the notation, let Yi be the response variable, Zi be the binary treatment assignment 
status (with value of 1 for treated and 0 for untreated), and Xi be all other observed 
covariates for individual i (=1, ···, n). The observation for each subject consists of (Yi, Zi, 
Xi). We shall use the lower case characters to denote the observed values for these variables 
as (yi, zi, xi). Estimation of the parameter αZ, i.e. the treatment effect of Z on the outcome, 
would be our primary interest.
The assumptions behind covariate adjustment by PS are as follows: (y(1), y(0)) ⊥ Z|X & 0 < 
e(x, θ1) < 1, i.e. the strongly ignorable treatment assignment assumption (1.3) and the 
linearity assumption in COROLLARY 4.3 of Rosenbaum and Rubin [2]. Here, y(1) and y(0) 
are the potential outcomes of a particular unit under the treated and control group. That is, 
y(1) and y(0) are the outcomes if the unit had been assigned to the treated group and the 
control group, respectively. They are never observed simultaneously in reality, and their 
relationship with the observed outcome y and the binary treatment assignment status z can 
be expressed as y = zy(1) + (1 − z)y(0). To adjust for confounding factors with respect to Z 
via propensity scores, we estimate the propensity score, i.e. e(x, θ1), by performing a first 
stage regression as follows.
 2.1. First Stage Regression
We model Z given X as: Z=z|X=x ~ f(z | x, θ1) where θ1 is the parameter vector associated 
with the first stage regression in which logistic regression model is often used in practice:
(1)
The unknown conditional probability, e(x, θ1) ≡ Pr(z=1|x, θ1), is the propensity score which 
is a function of x and θ1 = (β0, β)′. Hence, we can write the log-likelihood function for the 
first stage regression as:
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where . The parameter vector θ1 can be estimated via 
model (2) as θ1̂ = argmaxθ1 l1(θ1), from which we obtain an estimate for the propensity 
score:  and θ̂1 = (β̂0, β̂)′.
 2.2. Second Stage Regression
With the propensity score estimated, we plug it into the second stage regression model as a 
covariate: yi = α0 + αZzi + αeêi(xi, θ̂1) + εi with ε ≡ N(0, σ2) being the random measurement 
error term. The parameter vector θ2 = (α0, αZ, αe, σ2)′ which includes the effect of Z, αZ, 
our primary interest. This modeling scheme leads to the following log-likelihood function:
(3)
where f(yi | (zi, ei(x, θ1)); θ2) = ϕ(yi; α0 + αZzi + αeei, σ2) and the function ϕ(y; μ, σ2) is the 
normal density function with mean μ and variance σ2. To obtain the parameter estimates for 
θ2, i.e. θ̂2, we maximize the log-likelihood function and obtain  and its 
variance estimate based on the Fisher information matrix, from which the treatment effect 
estimate, α̂Z and its associated variance estimate denoted as  can be subsequently 
extracted. However, this variance estimator can be severely biased as will be shown in 
simulations (see Section 3). To address the biased variance estimation issue, we propose the 
following analytic variance estimator.
 Analytic Variance Estimator ( )—Realizing that êi(xi, θ̂1) is an estimated 
rather than observed quantity, we need to take into account the parameter estimation errors 
from the first stage regression during the second stage regression analysis. Specifically, we 
adopt the approach of Murphy and Topel (1985) by jointly modeling y and z given e(x) and 
x. This modeling strategy would allow us to derive an asymptotically valid variance estimate 
of α̂Z. Under this modeling strategy, we obtain the following joint log-likelihood function:
(4)
Instead of maximizing the above likelihood on θ1 and θ2 simultaneously, we can easily show 
that θ̂2 = arg maxθ2 l2(θ̂1, θ2), i.e. maximizing equation (4) on θ2 given θ
̂
1 which is estimated 
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from model (2). This modeling strategy is similar to the settings in Murphy and Topel (1985) 
which allows us to establish the asymptotic result of θ2̂ as summarized in Theorem 2.1 
below.
 Theorem 2.1: Under some regularity conditions, the treatment effect estimator α̂Z from 
the two-stage propensity score covariate adjustment via the analytic scheme (4) is 
asymptotically normally distributed with,
where  is the second diagonal element of the covariance matrix Σ given as the following:
with , and 
. Further, under the strongly ignorable treatment assignment 
assumption (1.3) and the linearity assumption in COROLLARY 4.3 of Rosenbaum and 
Rubin [2],  can be replaced by αZ, the true marginal treatment effect.
The above result provides us the basis for deriving a valid asymptotic variance estimate of 
α̂Z. A detailed mathematical derivation of Theorem 2.1 is presented in the Appendix. To 
estimate the covariance matrix Σ, we propose a sample estimate as follows:
where 
and , respectively. The proposed analytic variance estimator of α̂Z, 
i.e. , is the second diagonal element of the covariance matrix Σ̂. To 
complement the research, we present an empirical bootstrapping procedure (e.g. [9]) below 
for the variance estimate under the PS covariate adjustment analysis.
 Bootstrap Variance Estimator ( )—The bootstrapping procedure for the 
variance estimate of α̂Z proceeds as follows: i) for the bth(b = 1, ···, B) round of the 
bootstrapping procedure, where B is the total number of bootstraps, we sample subjects from 
the original dataset with replacement to generate new sampling data in which the PS 
covariate adjustment with conventional modeling (3) is performed to obtain the treatment 
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effect estimate as α̂Z,b; and ii) the bootstrap variance estimate of α̂Z is obtained as: 
 where .
The empirical bootstrapping procedure is conceptually simple and straightforward, but it 
could be computationally prohibitive for “big” observational data which usually contain 
millions of observations with hundreds of thousands of variables. It is therefore of both 
practical and theoretical interest to implement the analytic variance estimator for α̂Z, i.e. 
, as we developed above. Even though we focus on normally distributed outcomes 
in this paper, it is worth mentioning that the proposed two-stage PS covariate adjustment 
analytic strategy can be extended to other data types, such as binary outcomes with 
generalized linear or non-linear models.
 3. Simulation Studies
To evaluate the performance of the proposed variance estimators, we conduct simulation 
studies under various confounding settings. Specifically, we compare the proposed analytic 
variance estimator  and the empirical bootstrapping variance estimator 
with the conventional variance estimator  from the conventional PS covariate 
adjustment via the conventional modeling strategy (3).
Our simulations start with a simple confounding structure scenario and the complexity of the 
confounding structure is then increased step by step. In each of the simulation settings, we 
consider two different scenarios: i) all observed covariates are confounding factors; ii) some 
observed covariates are confounding factors and the other are nuisance variables. 
Simulations are run for 1000 replications with sample sizes of 500 and 5, 000, respectively.
 Simple Confounding Structure—In the first set of simulations, the treatment 
assignment is based on the following mechanism with total p = 10 confounding covariates:
(5)
where x1,i, ···, x5,i are continuous variables generated from N(0, 1) and x6,i, ···, x10,i are 
binary variables generated from Bern(0.5). To mimic the scenario for practical observational 
data, we generate another 10 covariates, i.e. x11,i, ···, x20,i as observed but they have neither 
effect on the treatment assignment status Z nor on the outcome Y and are referred as 
nuisance variables. Again the first five of them, i.e. x11,i, ···, x15,i are continuous and 
sampled from N(0, 1) while the rest, i.e. x16,i, ···, x20,i, are binary and sampled from 
Bern(0.5). For ease of description, we do not list the values of each of β = (β0, β1, ···, β10) but 
they are drawn from Unif(−1, 1) at the beginning of the simulation and they are fixed for all 
replications of the subsequent Monte Carlo simulations.
Outcomes are generated from the following simple linear model:
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where εi ~ N(0, 1) represents the random measurement error. The treatment effect, i.e. αZ, is 
fixed at 0.5. Again, we draw each parameter in (α0, α1, ···, α10) from Unif(−1, 1) at the 
beginning of the simulation and fix them for all simulations. Simulation results for this 
simple confounding structure are presented in the first half of Table 1 where the Column 
“Monte Carlo SE(α̂Z)” lists the Monte Carlo (MC) standard error of α̂Z which can be 
regarded as the true standard error of α̂Z. In addition, as a brief comparison with other PS-
based methods, we also present the results based on PS stratification (with 5 strata) and IPW 
by PS in the second half of Table 1.
Results from the first part of Table 1 suggest that the treatment effect estimates from the PS 
covariate adjustment modeling schemes are unbiased under different simulation settings. 
However, examining Table 1 more closely, we notice that the variance estimates from the 
covariate adjustment by PS with the conventional modeling scheme (3), , are 
severely biased. This problem persists even when the sample size increases. For example, in 
the scenario of sample size 500, p = 10, and q = 0, the mean standard error 0.277 is more 
than double of the MC standard error 0.117. Even when the sample size is increased to 5000, 
the mean standard error 0.086 is still more than double of the MC standard error 0.037. The 
bias in the variance estimate from the conventional PS covariate adjustment model is also 
reflected in the 95% confidence interval (CI) coverage. In contrast, the variance estimates 
from the two-stage analytic procedure, i.e. , the bootstrapping scheme, i.e. 
, are both almost identical to the true variance and offer confidence intervals with 
the targeted coverage.
The second part of Table 1 reveals that though IPW by PS offers unbiased treatment effect 
estimates, it is less efficient than covariate adjustment by PS while the PS stratification 
estimator can be biased slightly. The essence of IPW by PS is to create two virtual groups 
via the estimated PS such that the baseline covariates are balanced. The treatment effects 
estimate derived by comparing the outcomes between these two virtual groups under IPW is 
similar to the treatment effects estimate from fitting a simple ANOVA model under a 
randomized controlled trial setting. In contrast, the covariate adjustment by PS evaluates the 
treatment effects by plugging in the estimated PS as a covariate. Hence, the treatment effects 
estimator of the covariate adjustment by PS is similar to the treatment effects estimator of 
fitting an ANCOVA model under a randomized controlled setting. ANCOVA models are 
usually more efficient than ANOVA models (e.g. [10]). On the other hand, while PS 
stratification would allow unbiased treatment effects estimate in general, the treatment 
effects estimate could be biased if the stratum is not fine enough (e.g. stratum number is not 
large enough) though 5 strata are commonly used in practice (e.g. [11]).
Other than the simulation setting of αZ = 0.5, we also double and triple the treatment effect 
size of αZ while keeping other settings unchanged. Results for these settings are given in 
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Table 2. Similar conclusions are obtained, i.e. severely biased variance estimation persists if 
the conventional method is used while the proposed methods eliminate such bias.
To further investigate the robustness property of the proposed variance estimators, we 
conduct two additional simulations by varying the data generating model and the treatment 
allocation mechanism. Specifically, we consider the following two complex confounding 
structures:
Complex Confounding Structure I (quadratic covariate term in the PS model): we kept 
the data generating model (6) the same but change the treatment assignment from the 
generalize linear model (5) to the following allocation mechanism:
(7)
That is, the first continuous covariate x1,i affects the treatment assignment Z both linearly 
and quadratically. However, when estimating the propensity scores, we only include the 
linear terms of xi in the logistic regression fitting.
Complex Confounding Structure II (quadratic term in response model): we kept the 
treatment allocation mechanism (5) unchanged but vary the data generating model as 
follows:
(8)
In this simulation, the first continuous covariate x1,i affects the response yi quadratically. 
Again, we only use the linear terms of xi in the logistic regression to estimate the propensity 
score and conduct the PS covariate adjustment analysis with different modeling strategies to 
mimic the practical statistical analysis of large observational data sets. Simulation results for 
these two complex confounding structures are summarized in Table 3.
Results from the first part of Table 3 reveal that the bias of the variance estimate under the 
conventional PS covariate adjustment modeling (3) persists while the variance estimates 
from the proposed variance estimators are approximately unbiased and robust to the 
complex confounding structures. Similar observations hold (i.e. second part of Table 3) for 
the situation with different confounding structures where one of the covariates affects the 
response nonlinearly (i.e. quadratically), further demonstrating the robustness of both the 
analytic and empirical bootstrapping variance estimators. This robustness feature would be 
extremely useful for the analysis of big observational data where the relationship between 
the confounding factors and response variables may be much more complex than a simple 
linear relationship.
 4. An Application
To demonstrate a practical application of the proposed methods, we apply them to a post-
surgery pain data set obtained from the University of Florida Integrated Data Repository. 
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The study included 6511 patients who underwent different surgeries. One of the objectives 
of the study was to compare two anesthetic procedures, i.e. nerve block (Z = 1) versus 
general anesthesia (Z = 0), on relieving the post-surgery pain. Among the 6511 patients, 
4806 adopted nerve block procedure while the remaining 1705 opted for general anesthesia. 
The nerve block procedure interrupts signals traveling along a nerve and is often used for 
pain relief. Compared to the traditional anesthesia procedure, the nerve block procedure has 
some advantages by allowing patients to remain awake, thereby avoiding the adverse 
reactions of general anesthesia such as cognitive loss. However, the nerve block procedure 
may cause other side effects such as infections and less pain relief. The primary outcome of 
the study was the post-surgery pain score which is quantified numerically and scaled 
between 0 and 10, where the higher pain scores mean greater pain.
Covariates other than the treatment procedures (i.e. nerve block and anesthesia) include 
patient age, body mass index (BMI), surgery duration, ICD9 comorbidity count, ethnicity 
group, and primary current procedural terminology. Distributions of the baseline covariates 
by treatment group are presented in Table 4. Before conducting the analysis using the 
proposed method, we performed a sensitivity analysis (e.g. [12]) via a likelihood ratio test 
(e.g. [13]) to check the strongly ignorable treatment assignment assumption. The likelihood 
ratio test yielded a statistic of 0.003 (p-value = 0.954) suggesting that the strongly ignorable 
treatment assignment assumption holds reasonably well in this data set.
Results for five methods appear in Table 5. The first row of Table 5 presents the crude 
treatment effect estimate, i.e. −0.007, obtained without adjusting for any of the confounding 
covariates. This result indicates that the nerve block procedure can slightly relieve post-
surgery pain compared to the traditional anesthesia procedure, though this conclusion is not 
statistically significant. However, after adjusting for the confounding factors, the PS 
covariate adjustment gives a positive treatment effect estimate of 0.015, suggesting that the 
nerve block procedure gives less pain relief. Again, this conclusion is not statistically 
significant. It is evident that both the analytic and empirical bootstrapping variance 
estimators provide nearly identical standard errors (i.e. 0.055) for α̂Z and they are noticeably 
smaller (by 14.5%) than the conventional standard error (i.e. 0.063) obtained directly from 
the covariate adjustment by PS without acknowledging the fact that the PS scores are 
estimated with errors. This result is consistent with what we observed in the simulation 
studies though the difference from the traditional variance estimator is not remarkably large. 
A potential interpretation is that the confounding effects are not large in this clinical 
example. As a further comparison, we fit a multiple regression model including all the linear 
terms of the observed covariates in addition to the treatment allocation. The treatment effect 
estimate and its standard error are very close to the ones from the PS covariate adjustment 
with the proposed variance estimators, and the standard errors from the two methods are 
smaller than the one from the analysis without any covariate adjustment.
 5. Discussion
In this paper, we show that the variance estimation of the treatment effect estimates, 
obtained directly from the PS covariate adjustment without acknowledging the fact that the 
PS scores are estimated with errors, is biased in general and could lead to invalid statistical 
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inferences. The availability of our user-friendly software would enable investigators to easily 
apply the proposed covariate adjustment by PS analysis scheme to their studies and make 
valid statistical inferences.
Treating the PS covariate adjustment as a two-stage analysis enables us to establish the 
asymptotic results of the treatment effect estimates and propose a valid analytic variance 
estimator. The closed form analytic variance estimator is accurate and asymptotically 
consistent. More importantly, as our simulations indicate, it is also robust to model miss-
specifications where complex confounding structures exist. In addition to the analytic 
procedure, we also carry out an empirical bootstrap procedure that is straightforward but 
more computationally intensive. As shown in Simulation Studies section, the variance 
estimate from the proposed analytic variance estimators are not only very close to the true 
variance of treatment effect estimates but also they are smaller than that from the 
conventional variance estimator where the PS uncertainty is ignored. One plausible 
explanation is that the correlation between the true (unknown) propensity scores and the 
treatment assignment is exaggerated by the correlation between the estimated propensity 
scores and the treatment assignment, leading to an inflated variance estimate. Similar pattern 
has been observed by Zou and Fine [14] where parameter estimates derived from the 
likelihood function with plug-in estimator of the nuisance parameter vector can be more 
efficient than the ones derived from the likelihood function with known nuisance parameter 
vector.
It should be noted that the treatment effect based on covariate adjustment by PS method is a 
conditional treatment effect estimate. For linear treatment effects, for example, continuous 
data where the treatment effect is obtained by comparing the mean difference, it is 
collapsible, i.e. the conditional and marginal treatment effects are equivalent (e.g. [15]). The 
marginal and conditional treatment effects for binary outcomes are different if the treatment 
effect is evaluated through the odds ratio or risk ratio (e.g. [16]) since they are nonlinear 
treatment effects in these scenarios.
As an alternative to the covariate adjustment by PS, it is also common to run multiple 
regression analysis where all confounding factors are included as covariates in the regression 
model, in the same manner as we have done in Section 4. Our simulation results (not shown) 
indicate that the PS covariate adjustment analysis tends to provide as efficient treatment 
effect estimates as the multiple regression analysis when no complex confounding structures 
exist. However, the estimates from the PS covariate adjustment seem to be more robust than 
the ones from the multiple regression analysis when, for example, the linearity assumption is 
violated from the presence of complex confounding structures. This deserves further 
theoretical investigation, but is beyond the scope of this paper. Finally, it is worth 
mentioning that a limitation of all PS-based methods is that they can only adjust for 
observed confounding factors but not unobserved ones (e.g. [17]).
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 Appendix I: Proof of Theorem 2.1
Let  and  denote the true parameter values of θ1 and θ2 under the models (2) and (4). The 
MLEs of θ1 and θ2, i.e. θ̂1 and θ̂2 satisfy score equations:
(9)
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Under standard regularity conditions, θ1̂ is consistent. Therefore, the maximization of the 
quantity  is asymptotically equivalent to the maximization of 








By the central limit theorem, we conclude the joint distribution of statistics:
is bivariate normal and given by the following:
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By the law of large number theorem, the asymptotic equivalence of (13) can be written as 
the following:
(15)
Plugging (15) into (14) and applying the law of large number theorem, we have:
By the joint distribution of , we obtain the 
asymptotic distribution of θ2̂:
(16)
where Σ = V2 + V2[CV1CT − RV1CT − CV1RT]V2 with 
 and hence the conclusions follow.
 Appendix II: R Function for the Proposed Variance Estimators in PS 
Covariate Adjustment
# dmat: data matrix
#      1) first column is outcome
#      2) second column is treatment assignment
#      3) the rest are other observed covariates
# boot.num:   # of bootstrapping
#           <=0 indicating two–stage
# output:
#      1) trt.est: treatment effect estimate
#      2) trt.se: standard error based on the proposed estimator
#      3) naive.se: standard error based on conventional variance estimator
twoStagePS = function(dmat, boot.num=0) {
        n=dim(dmat)[1];
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        y=dmat[ ,1];
        trt=dmat[ , 2];
        x=as.matrix(dmat[,–c(1 ,2)]);
        psfit=glm(trt~x,family=binomial);
        ps=psfit$fitted;
        yfit=lm(y~trt+ps);
        ysum=(summary(yfit))$coefficients;
        if (boot.num <= 0) {
              newx=cbind(rep(1,n), x);
              tps=trt–ps;
              11th1=newx*matrix(tps,1,n)[,];
              y.res=yfit$resid;
              sigma2=sum(y.resˆ2)/(n–3);
              tem2=y.resˆ2/(2*sigma2) – 0.5;
              12th2=cbind(y.res,trt*y.res,ps*y.res,tem2)/sigma2;
              alphaP=ysum[3,1];
              ppstem1=ps*(1–ps)*y.res*alphaP/sigma2;
              ppstem2=trt*(1–ps)–(1–trt)*ps;
              ppstem=ppstem1+ppstem2;
              12th1=newx*matrix(ppstem,1,n)[,];
              V1mat=t(11th1)%*%11th1;
              V2mat=t(12th2)%*%12th2;
              Cmat=t(12th2)%*%12th1;
              Rmat=t(12th2)%*%11th1;
              new.V1=solve(V1mat);
              new.V2=solve(V2mat);
              CVmat1=Cmat%*%new.V1%*%t(Cmat);
              CVmat2=Rmat%*%new.V1%*%t(Cmat);
              CVmat3=Cmat%*%new.V1%*%t(Rmat);
              CVmat=CVmat1–CVmat2–CVmat3;
              Vmat=new.V2+new.V2%*%CVmat%*%new.V2;
              t.est=ysum[2,1];
              t.se=sqrt(Vmat[2,2]);
              n.se=ysum[2,2];
              return(list(trt.est=t.est,trt.se=t.se,naive.se=n.se));
        }
        boot.est=rep(0,boot.num);
        index=c(1:n);
        for (i in 1:boot.num) {
              nindex=sample(index,n,replace=T);
              ny=y[nindex];
              ntrt=trt[nindex];
              nx=x[nindex,];
              npsfit=glm(ntrt~nx,family=binomial);
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              nps=npsfit$fitted;
              nyfit=lm(ny~ntrt+nps);
              nysum=(summary(nyfit))$coefficients;
              boot.est[i]=nysum[2,1]
        }
        t.est=ysum[2,1];
        t.se=sqrt(var(boot.est));
        n.se=ysum[2,2];
        return(list(trt.est=t.est,trt.se=t.se,naive.se=n.se));
}
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Table 5
Analysis Results for Post-Surgery Pain Data
Method α̂Z SE(αẐ) 95% CI p-value
t-testa −0.007 0.061 (−0.127,0.113) 0.909
Multiple regressionb 0.013 0.056 (−0.097,0.123) 0.816
PS covariate adjustmentc 0.015 0.063 (−0.108,0.138) 0.812
PS covariate adjustmentd 0.015 0.055 (−0.093,0.123) 0.785
PS covariate adjustmente 0.015 0.055 (−0.093,0.123) 0.785
a
Two sample t-test without adjusting for any confounding factors
b




  with total 500 rounds of bootstrapping
e
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